Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research. This week, we have another exclusive interview from the ADA 2018 in Orlando.
Todd Hobbs, MD, is Vice President and Diabetes Chief Medical Officer for Novo Nordisk in North America, where he leads the organization’s focus on the implications of diabetes for the patient, healthcare system and healthcare professionals. As the Diabetes Chief Medical Officer for Novo Nordisk in North America, he focuses on the implications of diabetes for the company and for patients, for healthcare professionals and for healthcare systems. He provides medical guidance and input to the clinical development and life cycle management strategies for diabetes and obesity-related projects, as well as input into the R&D pipeline and participate in consultant advisory boards. Prior to joining the Novo Nordisk team in 2004, he attended the University of Louisville School of Medicine and then serviced as a resident at the Anderson Area Medical Center in South Carolina.
Featured videos include:
Pt.1: The Pioneer One Study
Pt.3: Trulicity Versus Ozempic
Pt.5: The Confirm Study
or view the complete interview here: Full Interview.